XML 31 R13.htm IDEA: XBRL DOCUMENT v3.24.1
Note 7 - Discontinued Operations - Sale of OMIDRIA
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

Note 7—Discontinued Operations - Sale of OMIDRIA

 

On December 23, 2021, we closed the sale of OMIDRIA and related assets, which is reported as discontinued operations in our consolidated statements of operations and comprehensive income. Upon closing, we received an up-front cash payment from Rayner of $126.0 million, and we retained the outstanding receivables and liabilities related to OMIDRIA as of the closing date.

 

The year ended December 31, 2021, included a gain on the sale of OMIDRIA comprised as follows (in thousands):

 

Cash proceeds

 $125,993 

OMIDRIA contract royalty asset

  184,570 

Gain on sale of OMIDRIA, gross

  310,563 

Transaction and closing costs

  (1,972)

RSUs granted to transferred employees

  (1,419)

Prepaid assets and inventory at cost

  (1,524)

Gain on sale of OMIDRIA

 $305,648 

 

In December 2022, the achievement of the Milestone Event triggered a $200.0 million Milestone Payment from Rayner which we received in February 2023. The Milestone Event also resulted in a reduction in the U.S. royalty rate from 50% to 30% on OMIDRIA net sales. 

 

The results of operations for OMIDRIA are recorded as income from discontinued operations for all periods presented in the consolidated statements of operations and comprehensive income (loss).

 

  

Year Ended December 31,

 
  

2023

  

2022

  

2021

 
  

(In thousands)

 

Product sales, net

 $  $  $110,735 

Costs and expenses

        30,631 

Gross margin

        80,104 

Gain on sale of OMIDRIA

        305,648 

Milestone income

     200,000    

Interest on OMIDRIA contract royalty asset

  15,315   18,634    

Remeasurement adjustments

  41,167   14,457    

Other income

  1,087   307   1,035 

Income before income tax

  57,569   233,398   386,787 

Income tax expense (1)

  (462)  (3,952)  (1,006)

Net income from discontinued operations, net of tax

 $57,107  $229,446  $385,781 

 

(1) For further discussion of income tax expense refer to “Note 13 – Income Taxes”.

 

The following schedule is a rollforward of the OMIDRIA contract royalty asset (in thousands):

 

Balance at December 31, 2021

 $184,570 

Royalties earned

  (65,439)

Interest on OMIDRIA contract royalty asset

  18,634 

Remeasurement adjustments

  14,457 

Balance at December 31, 2022

  152,222 

Royalties earned

  (40,595)

Interest on OMIDRIA contract royalty asset

  15,315 

Remeasurement adjustments

  41,167 

Balance at December 31, 2023

 $168,109 

 

Cash flow from discontinued operations is as follows:

 

  

Year Ended December 31,

 
  

2023

  

2022

  

2021

 
  

(In thousands)

 

Net cash provided by discontinued operations from operating activities

 $241,317  $78,082  $55,380 

Net cash provided by discontinued operations from investing activities

 $  $  $125,993